Aug 22 (Reuters) - Getinge AB: * GETINGE TO ACQUIRE PARAGONIX TECHNOLOGIES, A GROWTH LEADER IN THE ORGAN TRANSPLANTATION MARKET * GETINGE AB - ACQUIRES PARAGONIX TECHNOLOGIES FOR USD 477 MILLION * GETINGE - AGGREGATED UPFRONT PURCHASE PRICE OF $477 MILLION, OF WHICH USD 253 MILLION IS PAYABLE IN CASH ON CLOSING * GETINGE - ACQUISITION WILL BE FINANCED THROUGH...

04:15 PM EDT, 08/22/2024 (MT Newswires) -- Leonardo DRS ( DRS ) said Thursday it won a $49 million contract to build more Joint assault bridge systems for the US Army and the Romanian military. In partnership with the US Army, we have successfully delivered more than 100 of the next-generation systems, the company said. Price: 28.50, Change: +0.44, Percent...

04:18 PM EDT, 08/22/2024 (MT Newswires) -- Intuit (INTU) reported fiscal Q4 non-GAAP earnings late Thursday of $1.99 per diluted share, up from $1.65 a year earlier. Analysts polled by Capital IQ expected $1.85. Revenue in the quarter ended July 31 rose to $3.18 billion from $2.71 billion a year earlier. Analysts surveyed by Capital IQ expected $3.09 billion. For...

04:16 PM EDT, 08/22/2024 (MT Newswires) -- Carole Ho, Chief Medical Officer, on August 20, 2024, sold 22,458 shares in Denali Therapeutics ( DNLI ) for $549,928. Following the Form 4 filing with the SEC, Ho has control over a total of 327,029 shares of the company, with 118,810 shares held directly and 208,219 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1714899/000171489924000194/xslF345X05/wk-form4_1724357642.xml ...